Last edition
News about
IIL to invest Rs700 Cr in Hyd for new animal vaccine facility
The facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) for Drug substance (DS) production and respective fill-finish
Amneal Pharma begins commercial operations in India
Appoints Shyamakant Giri as Managing Director and President for India Business and Emerging Markets
Novavax terminates Fujifilm manufacturing deal
Novavax will pay the sum in four quarterly installments of $34.3 million starting on March 31, 2023
EDQM conducts GMP inspection at Biocon's API site in Bengaluru
As per the filing, the inspection was held between September 12-14, 2022 and issued a list of deficiencies on October 5, 2022
Logistics4Pharma to expand operations with ultra deep-freeze capabilities
The recent investment in ultra-deep-freeze (UDF) warehousing for temperatures as low as -80 Deg C enables the storage of highly sensitive medicines such as proteins and COVID-19 vaccines
Lupin appoints Shahin Fesharaki as Global Chief Scientific Officer
Fesharaki will be in charge of Lupin's global R&D operations spanning branded, generic, and speciality products
Eisai completes construction of new injection/research building at Kawashima Industrial Park, Japan
Eisai Medicine Innovation Technology Solutions will be Eisai's global base for formulation and modality research
Merck opens secondary packaging facility in Singapore
Announces another plant that will produce inhalers and is set for completion in 2026
Zydus Lifesciences-led arm bags US FDA approval for Brivaracetam tabs
The medicine would be produced at the group's formulation manufacturing plant in Ahmedabad Special Economic Zone
<br />
US FDA issues EIR to Suven Pharma's subsidiary
The pre-approval inspection was conducted between July 25 to July 29, 2022
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy